Flourish Mushroom Labs Enters into Definitive Agreement and Completes License of Mushroom Extraction Technology


Ryan Allway

March 3rd, 2020

News


March 3, 2020 – Vancouver, BC: The Yield Growth Corp.  (CSE:BOSS) (OTCQB:BOSQF) (FE:YG3) subsidiary Flourish Mushroom Labs Inc. announces that it has  licensed to Kingdom Brands Inc. the U.S. rights to its mushroom extract manufacturing technology, which is protected by a U.S. provisional patent application (the “Technology”).

The patent application covers the invention of a unique mushroom extract and a method of manufacturing the extract from mushrooms including psilocybe mexicana, and formulations and emulsions containing the mushroom extract.  The mushroom extract may be in the form of an aqueous solution, or it may be a freeze or spray dried powder.

Yield Growth previously announced on February 13, 2020 that it’s subsidiary, Flourish Mushroom Labs, had entered into a non binding LOI whereby Kingdom Brands agreed to pay CAD $500,000 to Flourish in exchange for the rights to use and sub-license and further develop the Technology in the United States for use with both medicinal and psychedelic mushrooms. The parties entered into a definitive agreement on February 21, 2020 for the license and the payment of $500,000 through the issuance of stock in Kingdom Brands, which is now complete, and Kingdom has acquired the U.S. rights to the Technology.

Kingdom Brands’ subsidiary leases a property in California which may be suitable to cultivate medicinal mushrooms and to manufacture mushroom extract. The company plans to position itself in the marketplace to serve the potential demand that may follow the potential legalization of psilocybin.

Major strides have been taken towards the decriminalization of psilocybin mushrooms in Washington D.C, California, Colorado, Vermont and Oregon. In California, the California Psilocybin Decriminalization Initiative, which envisions  the implementation of a comprehensive, state-wide scheme authorizing and regulating the cultivation, processing and distribution of psilocybin mushrooms, has the potential to be on the state ballot in November 2020.

Kingdom Brands completed payment of $500,000 to Flourish through the issuance of 5,000,000 shares in exchange for the rights to use and sub-license the Technology in the United States. Yield Growth, through its subsidiaries, currently owns approximately 19% of Kingdom Brands and provides incubation services to Kingdom Brands through an operating agreement.  Kingdom Brands has recently signed an engagement letter with a Canadian investment dealer as agent, on a best efforts basis, to an initial public offering (the “IPO”) to raise between $2,000,000 and $4,000,000 in Canada and list on a Canadian stock exchange.  The completion of the IPO is subject to due diligence, regulatory approval and other conditions.

About Flourish Mushroom Labs Inc.

Flourish Mushroom Labs aims to legally and safely commercialize psilocybin (magic) mushrooms and improve life by offering high-quality medicinal mushroom infused products. Flourish Mushroom Labs is conducting research into potential therapeutic benefits of compounds found in magic mushrooms. It has filed U.S. patent applications for its extraction technology and  for certain therapeutic uses of psilocybin and magic magic mushrooms.  Flourish Mushroom Labs is a majority owned subsidiary of The Yield Growth Corp.

About The Yield Growth Corp.

The Yield Growth Corp. is a health and beauty consumer packaged goods company selling plant-based products.  It has over 200 proprietary beauty, wellness, edibles and beverage formulas at various stages of commercialization.  Its products are sold through e-commerce worldwide and in retail stores in 3 countries with distribution agreements in place for 12 more countries.  It conducts research for plant-based therapeutics and has filed 15 patent applications in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market.  It owns the skin care brand Urban Juve, which has been featured in UK Vogue and Elle Canada, and it owns cannabis brands Wright & Well and Jack n Jane. Its majority owned subsidiary Flourish Mushroom Labs is launching a line of medicinal mushroom products and developing intellectual property and assets in the emerging market of psychedelic medicine.  The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia. Yield Growth earns revenue through multiple streams including licensing, services and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny White, President & CEO

Kristina Pillon, Investor Relations

invest@yieldgrowth.com

1-833-514-BOSS   1-833-514-2677

1-833-515-BOSS   1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation.  Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements.  Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, the potential for not acquiring any rights as a result of the patent  application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen.  The laws around cultivating, selling and using psychedelic mushrooms would need to change in most jurisdictions in order for the use of psychedelic products to be legal and sale of, and demand for, Urban Juve, Wright & Well, Flourish Mushroom Labs, Jack n Jane and UJ Beverages products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets.  Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading